Your browser doesn't support javascript.
loading
IFN-Gamma Expression in the Tumor Microenvironment and CD8-Positive Tumor-Infiltrating Lymphocytes as Prognostic Markers in Urothelial Cancer Patients Receiving Pembrolizumab.
Sakatani, Toru; Kita, Yuki; Fujimoto, Masakazu; Sano, Takeshi; Hamada, Akihiro; Nakamura, Kenji; Takada, Hideaki; Goto, Takayuki; Sawada, Atsuro; Akamatsu, Shusuke; Kobayashi, Takashi.
Afiliação
  • Sakatani T; Department of Urology, Graduate School of Medicine, Kyoto University, Kyoto 606-8507, Japan.
  • Kita Y; Department of Urology, Graduate School of Medicine, Kyoto University, Kyoto 606-8507, Japan.
  • Fujimoto M; Department of Diagnostic Pathology, Graduate School of Medicine, Kyoto University, Kyoto 606-8507, Japan.
  • Sano T; Department of Urology, Graduate School of Medicine, Kyoto University, Kyoto 606-8507, Japan.
  • Hamada A; Department of Urology, Graduate School of Medicine, Kyoto University, Kyoto 606-8507, Japan.
  • Nakamura K; Department of Urology, Graduate School of Medicine, Kyoto University, Kyoto 606-8507, Japan.
  • Takada H; Department of Urology, Graduate School of Medicine, Kyoto University, Kyoto 606-8507, Japan.
  • Goto T; Department of Urology, Graduate School of Medicine, Kyoto University, Kyoto 606-8507, Japan.
  • Sawada A; Department of Urology, Graduate School of Medicine, Kyoto University, Kyoto 606-8507, Japan.
  • Akamatsu S; Department of Urology, Graduate School of Medicine, Kyoto University, Kyoto 606-8507, Japan.
  • Kobayashi T; Department of Urology, Graduate School of Medicine, Kyoto University, Kyoto 606-8507, Japan.
Cancers (Basel) ; 14(2)2022 Jan 06.
Article em En | MEDLINE | ID: mdl-35053427

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article